BLFS profile · all as-reported value updates
BIOLIFE SOLUTIONS INC (BLFS) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Net income | 2018 | 3,266,000 | -25,005,000 | -28,271,000 | -113.06% | revised comparative figure | 0001437749-19-004980 0001437749-20-011046 | 2 filed observations examined for this concept and period. |
| Operating income | 2022 | -145,541,000 | -5,923,000 | 139,618,000 | +95.93% | revised comparative figure | 0001437749-23-008875 0001628280-25-009511 | 3 filed observations examined for this concept and period. |
| Liabilities | 2018 | 2,319,000 | 30,835,000 | 28,516,000 | +92.48% | revised comparative figure | 0001437749-19-004980 0001437749-20-011046 | 2 filed observations examined for this concept and period. |
| Operating income | 2023 | -70,825,000 | -17,205,000 | 53,620,000 | +75.71% | revised comparative figure | 0001628280-24-008061 0001628280-26-012294 | 3 filed observations examined for this concept and period. |
| Stockholders' equity | 2018 | 43,148,000 | 14,632,000 | -28,516,000 | -66.09% | revised comparative figure | 0001437749-19-004980 0001437749-22-007869 | 4 filed observations examined for this concept and period. |
| Revenue | 2022 | 161,759,000 | 76,239,000 | -85,520,000 | -52.87% | revised comparative figure | 0001437749-23-008875 0001628280-25-009511 | 3 filed observations examined for this concept and period. |
| Revenue | 2023 | 143,271,000 | 68,016,000 | -75,255,000 | -52.53% | revised comparative figure | 0001628280-24-008061 0001628280-26-012294 | 3 filed observations examined for this concept and period. |
| Operating income | 2024 | -7,129,000 | -4,477,000 | 2,652,000 | +37.20% | revised comparative figure | 0001628280-25-009511 0001628280-26-012294 | 2 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2023 | 35,407,000 | 27,896,000 | -7,511,000 | -21.21% | revised comparative figure | 0001628280-24-008061 0001628280-25-009511 | 2 filed observations examined for this concept and period. |
| Net income | 2021 | -7,635,000 | -8,908,000 | -1,273,000 | -14.29% | revised comparative figure | 0001437749-22-007869 0001628280-24-008061 | 3 filed observations examined for this concept and period. |
| Revenue | 2024 | 82,254,000 | 74,647,000 | -7,607,000 | -9.25% | revised comparative figure | 0001628280-25-009511 0001628280-26-012294 | 2 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2024 | 95,386,000 | 91,538,000 | -3,848,000 | -4.03% | revised comparative figure | 0001628280-25-009511 0001628280-26-012294 | 2 filed observations examined for this concept and period. |
| Operating income | 2021 | -33,940,000 | -35,160,000 | -1,220,000 | -3.47% | revised comparative figure | 0001437749-22-007869 0001628280-24-008061 | 3 filed observations examined for this concept and period. |
| Liabilities | 2021 | 73,920,000 | 76,239,000 | 2,319,000 | +3.04% | revised comparative figure | 0001437749-22-007869 0001437749-23-008875 | 2 filed observations examined for this concept and period. |
| Net income | 2023 | -66,427,000 | -68,002,000 | -1,575,000 | -2.32% | revised comparative figure | 0001628280-24-008061 0001628280-26-012294 | 3 filed observations examined for this concept and period. |